110 related articles for article (PubMed ID: 33250054)
21. COVID-19 and Cannabidiol (CBD).
Khalsa JH; Bunt G; Maggirwar SB; Kottilil S
J Addict Med; 2021 Sep-Oct 01; 15(5):355-356. PubMed ID: 33323690
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V
Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in Cannabis sativa genomics research.
Hurgobin B; Tamiru-Oli M; Welling MT; Doblin MS; Bacic A; Whelan J; Lewsey MG
New Phytol; 2021 Apr; 230(1):73-89. PubMed ID: 33283274
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy.
Cáceres Guido P; Riva N; Caraballo R; Reyes G; Huaman M; Gutierrez R; Agostini S; Fabiana Delaven S; Pérez Montilla CA; García Bournissen F; Schaiquevich P
Epilepsia; 2021 Jan; 62(1):e7-e12. PubMed ID: 33280111
[TBL] [Abstract][Full Text] [Related]
25. Rapid identification of drug-type and fiber-type cannabis by allele specific duplex PCR.
Yamamuro T; Segawa H; Kuwayama K; Tsujikawa K; Kanamori T; Iwata YT
Forensic Sci Int; 2021 Jan; 318():110634. PubMed ID: 33278699
[TBL] [Abstract][Full Text] [Related]
26. Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease.
Argueta DA; Aich A; Muqolli F; Cherukury H; Sagi V; DiPatrizio NV; Gupta K
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33271850
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol attenuated the maintenance and reinstatement of extinguished methylphenidate-induced conditioned place preference in rats.
Kashefi A; Tomaz C; Jamali S; Rashidy-Pour A; Vafaei AA; Haghparast A
Brain Res Bull; 2021 Jan; 166():118-127. PubMed ID: 33264654
[TBL] [Abstract][Full Text] [Related]
29. Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence.
Stewart C; Fong Y
JAMA Surg; 2021 Feb; 156(2):181-190. PubMed ID: 33263719
[TBL] [Abstract][Full Text] [Related]
30. Use of Cannabis for Self-Management of Chronic Pelvic Pain.
Carrubba AR; Ebbert JO; Spaulding AC; DeStephano D; DeStephano CC
J Womens Health (Larchmt); 2021 Sep; 30(9):1344-1351. PubMed ID: 33252316
[No Abstract] [Full Text] [Related]
31. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.
Reece AS; Hulse GK
BMC Cancer; 2021 Feb; 21(1):197. PubMed ID: 33632159
[TBL] [Abstract][Full Text] [Related]
32. Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.
Reece AS; Hulse GK
Front Psychiatry; 2023; 14():1182535. PubMed ID: 37732074
[TBL] [Abstract][Full Text] [Related]
33. A systematic review of
Sujan AC; Pal A; Avalos LA; Young-Wolff KC
Front Pediatr; 2023; 11():1149401. PubMed ID: 37303758
[TBL] [Abstract][Full Text] [Related]
34. The emerging roles of Hedgehog signaling in tumor immune microenvironment.
Wang J; Cui B; Li X; Zhao X; Huang T; Ding X
Front Oncol; 2023; 13():1171418. PubMed ID: 37213270
[TBL] [Abstract][Full Text] [Related]
35. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
36. Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Pediatr Rep; 2023 Feb; 15(1):69-118. PubMed ID: 36810339
[TBL] [Abstract][Full Text] [Related]
37. Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.
Reece AS; Hulse GK
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672773
[TBL] [Abstract][Full Text] [Related]
38. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554603
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological Patterns of Cannabis- and Substance- Related Congenital Uronephrological Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360648
[TBL] [Abstract][Full Text] [Related]
40. Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
